RM Kacmarek, R Ripple, BA Cockrill, KJ Bloch, WM Zapol and DC Johnson
Respiratory Care Department, Massachusetts General Hospital, Boston 02114, USA.

Nitric oxide (NO) reduces airway tone in the methacholine-treated guinea pig. We examined whether low levels of inhaled NO gas would relax airway smooth muscle tone in patients with mild asthma subjected to methacholine-induced bronchospasm. Thirteen adult volunteers with mild asthma inspired increasing concentrations of methacholine until their baseline forced expiratory volume in one second (FEV1, 3.29 +/- 0.17 L, mean +/- SEM) decreased by > or = 20% (2.33 +/- 0.18 L, p < 0.01). Thereafter, they sequentially inhaled 100 parts per million (ppm) NO, 40% O2; 40% O2; and 100 ppm NO, 40% O2 while spirometry was performed. Subsequent inhalation of isoproterenol returned the FEV1 levels to baseline. Inhaling 100 ppm NO increased FEV1 to 2.66 +/- 0.18 L (p < 0.01), and this increase was maintained after NO was discontinued. FEV1 did not change during the second period of NO inhalation. Similar results were observed for vital capacity, but no significant effect was noted on forced expiratory flow at 25% of vital capacity or peak expiratory flow. Subjects were then divided into a responder subgroup, which showed a mean increase in FEV1 after initial NO inhalation of 560 +/- 150 ml, and a nonresponder subgroup, which showed a mean increase in FEV1 of 129 +/- 29 ml. Our data suggest that inhalation of nitric oxide by patients with mild asthma with methacholine-induced bronchospasm results in a minor but significant relaxation of airway tone.

This article has been cited by other articles:

				M. Yang, D. Rangasamy, K. I. Matthaei, A. J. Frew, N. Zimmmermann, S. Mahalingam, D. C. Webb, D. J. Tremethick, P. J. Thompson, S. P. Hogan, et al. Inhibition of Arginase I Activity by RNA Interference Attenuates IL-13-Induced Airways Hyperresponsiveness J. Immunol., October 15, 2006; 177(8): 5595 - 5603. [Abstract] [Full Text] [PDF]

				M. Taniguchi, Y. L. Kwak, K. A. Jones, D. O. Warner, and W. J. Perkins Nitric oxide sensitivity in pulmonary artery and airway smooth muscle: a possible role for cGMP responsiveness Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L1018 - L1027. [Abstract] [Full Text] [PDF]

				Y. L. Kwak, K. A. Jones, D. O. Warner, and W. J. Perkins NO responsiveness in pulmonary artery and airway smooth muscle: the role of cGMP regulation Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L200 - L208. [Abstract] [Full Text] [PDF]

				C. R. Morris, M. Poljakovic, L. Lavrisha, L. Machado, F. A. Kuypers, and S. M. Morris Jr. Decreased Arginine Bioavailability and Increased Serum Arginase Activity in Asthma Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 148 - 153. [Abstract] [Full Text] [PDF]

				M. Peters-Golden The Alveolar Macrophage: The Forgotten Cell in Asthma Am. J. Respir. Cell Mol. Biol., July 1, 2004; 31(1): 3 - 7. [Full Text] [PDF]

				J. Hjoberg, S. Shore, L. Kobzik, S. Okinaga, A. Hallock, J. Vallone, V. Subramaniam, G. T. De Sanctis, J. A. Elias, J. M. Drazen, et al. Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness J Appl Physiol, July 1, 2004; 97(1): 249 - 259. [Abstract] [Full Text] [PDF]

				F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts Nitric Oxide in Health and Disease of the Respiratory System Physiol Rev, July 1, 2004; 84(3): 731 - 765. [Abstract] [Full Text] [PDF]

				F. Ichinose, J. D. Roberts Jr, and W. M. Zapol Inhaled Nitric Oxide: A Selective Pulmonary Vasodilator: Current Uses and Therapeutic Potential Circulation, June 29, 2004; 109(25): 3106 - 3111. [Full Text] [PDF]

				A. M. Hamad, A. Clayton, B. Islam, and A. J. Knox Guanylyl cyclases, nitric oxide, natriuretic peptides, and airway smooth muscle function Am J Physiol Lung Cell Mol Physiol, November 1, 2003; 285(5): L973 - L983. [Abstract] [Full Text] [PDF]

				P. R. Eynott, N. Paavolainen, D. A. Groneberg, A. Noble, M. Salmon, P. Nath, S.-Y. Leung, and K. F. Chung Role of Nitric Oxide in Chronic Allergen-Induced Airway Cell Proliferation and Inflammation J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 22 - 29. [Abstract] [Full Text] [PDF]

				O. E. Suman and K. C. Beck Role of airway endogenous nitric oxide on lung function during and after exercise in mild asthma J Appl Physiol, December 1, 2002; 93(6): 1932 - 1938. [Abstract] [Full Text] [PDF]

				A. TERADA, T. FUJISAWA, K. TOGASHI, T. MIYAZAKI, H. KATSUMATA, J. ATSUTA, K. IGUCHI, H. KAMIYA, and H. TOGARI Exhaled Nitric Oxide Decreases during Exercise-induced Bronchoconstriction in Children with Asthma Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1879 - 1884. [Abstract] [Full Text] [PDF]

				A E Redington, Q-H Meng, D R Springall, T J Evans, C Créminon, J Maclouf, S T Holgate, P H Howarth, and J M Polak Increased expression of inducible nitric oxide synthase and cyclo-oxygenase-2 in the airway epithelium of asthmatic subjects and regulation by corticosteroid treatment Thorax, May 1, 2001; 56(5): 351 - 357. [Abstract] [Full Text]

				O. E. Suman, J. D. Morrow, K. A. O'Malley, and K. C. Beck Airway function after cyclooxygenase inhibition during hyperpnea-induced bronchoconstriction in guinea pigs J Appl Physiol, November 1, 2000; 89(5): 1971 - 1978. [Abstract] [Full Text] [PDF]

				J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745. [Full Text]

				H. E. Marshall and J. S. Stamler NO Waiting to Exhale in Asthma Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 685 - 687. [Full Text] [PDF]

				A. M. Hamad, S. R. Johnson, and A. J. Knox Antiproliferative effects of NO and ANP in cultured human airway smooth muscle Am J Physiol Lung Cell Mol Physiol, November 1, 1999; 277(5): L910 - L918. [Abstract] [Full Text] [PDF]

				B. Raychaudhuri, R. Dweik, M. J. Connors, L. Buhrow, A. Malur, J. Drazba, A. C. Arroliga, S. C. Erzurum, M. S. Kavuru, and M. J. Thomassen Nitric Oxide Blocks Nuclear Factor-kappa B Activation in Alveolar Macrophages Am. J. Respir. Cell Mol. Biol., September 1, 1999; 21(3): 311 - 316. [Abstract] [Full Text]

				G. T. De Sanctis, J. A. MacLean, K. Hamada, S. Mehta, J. A. Scott, A. Jiao, C. N. Yandava, L. Kobzik, W. W. Wolyniec, A. J. Fabian, et al. Contribution of Nitric Oxide Synthases 1, 2, and 3 to Airway Hyperresponsiveness and Inflammation in a Murine Model of Asthma J. Exp. Med., May 17, 1999; 189(10): 1621 - 1630. [Abstract] [Full Text] [PDF]

				A. M. Hamad, S. P. Range, E. Holland, and A. J. Knox Desensitization of Guanylyl Cyclases in Cultured Human Airway Smooth-Muscle Cells Am. J. Respir. Cell Mol. Biol., May 1, 1999; 20(5): 1087 - 1095. [Abstract] [Full Text]

				K. A. Jones, G. Y. Wong, C. J. Jankowski, M. Akao, and D. O. Warner cGMP modulation of Ca2+ sensitivity in airway smooth muscle Am J Physiol Lung Cell Mol Physiol, January 1, 1999; 276(1): L35 - L40. [Abstract] [Full Text] [PDF]

				J. DE BOER, F.M. H. POUW, J. ZAAGSMA, and H. MEURS Effects of Endogenous Superoxide Anion and Nitric Oxide on Cholinergic Constriction of Normal and Hyperreactive Guinea Pig Airways Am. J. Respir. Crit. Care Med., December 1, 1998; 158(6): 1784 - 1789. [Abstract] [Full Text] [PDF]

				P. J. Barnes, K. F. Chung, and C. P. Page Inflammatory Mediators of Asthma: An Update Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596. [Abstract] [Full Text] [PDF]

				H. Takano, H.-B. Lim, Y. Miyabara, T. Ichinose, T. Yoshikawa, and M. Sagai Oral Administration of L-Arginine Potentiates Allergen-Induced Airway Inflammation and Expression of Interleukin-5 in Mice J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 767 - 771. [Abstract] [Full Text]